Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Aditxt Inc (ADTX)

Aditxt Inc (ADTX)
0.1769 x 246 0.1800 x 113
Post-market by (Cboe BZX)
0.1682 -0.0255 (-13.16%) 01/08/25 [NASDAQ]
0.1769 x 246 0.1800 x 113
Post-market 0.1799 +0.0117 (+6.96%) 19:59 ET
Quote Overview for Wed, Jan 8th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.1515
Day High
0.1900
Open 0.1896
Previous Close 0.1937 0.1937
Volume 28,676,801 28,676,801
Avg Vol 11,084,975 11,084,975
Stochastic %K 12.58% 12.58%
Weighted Alpha -98.69 -98.69
5-Day Change -0.0216 (-11.38%) -0.0216 (-11.38%)
52-Week Range 0.1515 - 253.6000 0.1515 - 253.6000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,394
  • Shares Outstanding, K 14,234
  • Annual Sales, $ 650 K
  • Annual Income, $ -32,380 K
  • EBIT $ -30 M
  • EBITDA $ -27 M
  • 60-Month Beta 1.26
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book 0.18
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -644.27
  • Most Recent Earnings $-111.07 on 11/18/24
  • Next Earnings Date 11/19/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1515 +11.02%
on 01/08/25
Period Open: 0.3491
0.3650 -53.92%
on 12/11/24
-0.1809 (-51.82%)
since 12/06/24
3-Month
0.1515 +11.02%
on 01/08/25
Period Open: 1.4100
1.8599 -90.96%
on 10/15/24
-1.2418 (-88.07%)
since 10/08/24
52-Week
0.1515 +11.02%
on 01/08/25
Period Open: 206.4000
253.6000 -99.93%
on 01/11/24
-206.2318 (-99.92%)
since 01/08/24

Most Recent Stories

More News
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome

Aditxt®, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that modulate and monitor the immune system, today announces that...

ADTX : 0.1682 (-13.16%)
Aditxt (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered...

ADTX : 0.1682 (-13.16%)
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced...

ADTX : 0.1682 (-13.16%)
Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a definitive agreement. The company...

ADTX : 0.1682 (-13.16%)
Aditxt (NASDAQ: ADTX) Inks Agreement for 50% Ownership of Global Response Aid

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, has signed an asset purchase agreement with Cellvera Ltd. According...

ADTX : 0.1682 (-13.16%)
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that...

ADTX : 0.1682 (-13.16%)
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan

Aditxt,® Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to announce...

RDY : 15.81 (+0.89%)
ADTX : 0.1682 (-13.16%)
Aditxt (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has released a shareholder update outlining its three...

ADTX : 0.1682 (-13.16%)
Aditxt Issues Shareholder Update

Aditxt,® Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide...

ADTX : 0.1682 (-13.16%)
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer

Aditxt, Inc. , (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is pleased...

ADTX : 0.1682 (-13.16%)

Business Summary

Aditx Therapeutics Inc. is a life sciences company. It engages in developing biotechnologies specifically focused on health of the immune system through immune monitoring and reprogramming. Aditx Therapeutics Inc. is based in LOMA LINDA, CA.

See More

Key Turning Points

3rd Resistance Point 0.2268
2nd Resistance Point 0.2084
1st Resistance Point 0.1883
Last Price 0.1682
1st Support Level 0.1498
2nd Support Level 0.1314
3rd Support Level 0.1113

See More

52-Week High 253.6000
Fibonacci 61.8% 156.7827
Fibonacci 50% 126.8758
Fibonacci 38.2% 96.9688
Last Price 0.1682
52-Week Low 0.1515

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world